RxDoctor Payments Data

Baran Aksut

Interventional Cardiology · Lone Tree, CONPI 1063770048

Payments from drug & device makers

What this record shows

This record is dominated by grants: $23,500 of the $31,918 with a category attached, or 73.6%. 26 manufacturers reported payments, led by Boston Scientific at 41.9% of the total. Reporting peaked in 2022 at $24,840 and has fallen 95.7% since, to $1,062 in 2025.

$31,918in general payments, 2019–2025

Across 381 payments — averaging $83.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$13K
  • Medtronic$13K
  • Edwards Lifesciences$2K
  • Abbott$1K
  • Philips North America LLC$578
  • Angiodynamics, Inc.$256
  • plus $2K from 20 others
$50in research payments, 2019–2025

Across 1 payment — averaging $49.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abiomed$50

What the payments were for

  • Grants$23,50074%
  • Travel & lodging$8623%
  • Food & beverage$7,55624%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,918 in reported general payments places this provider in the 75th percentile of 111 interventional cardiology providers in Colorado.

See all interventional cardiology providers in Colorado

Medicare billing

Part B allowed, 2024
$81,001
Medicare patients
275
Services billed
820

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium13$161
Potassium Chloride13$140
Carvedilol12$74

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Lone Tree

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →